サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1423999

ハドロン療法市場、シェア、市場規模、動向、産業分析レポート：タイプ別、用途別、エンドユーザー別、地域別、セグメント別予測、2024-2032年

Hadron Therapy Market Share, Size, Trends, Industry Analysis Report, By Type (Electron Beam, Proton Beam, Neutron Beam, Carbon Ion Beam, Alpha Particle Beam, and Beta Particle Beam); By Application; By End User; By Region; Segment Forecast, 2024-2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 114 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.70円
ハドロン療法市場、シェア、市場規模、動向、産業分析レポート：タイプ別、用途別、エンドユーザー別、地域別、セグメント別予測、2024-2032年
出版日: 2024年01月24日
発行: Polaris Market Research
ページ情報: 英文 114 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界のハドロン療法市場規模は2032年までに47億2,000万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

世界のがんの有病率の増加、技術進歩の進展による治療期間の短縮、ハドロン療法の潜在的な有用性を認識し、新たなセンターの設立に財政的支援を提供する政府の増加などが、市場の成長に影響を与える顕著な要因となっています。さらに、改善された治療オプションの重要性と利用可能性に関するヘルスケア専門家と一般市民の意識の高まり、教育イニシアティブとトレーニングプログラムの成長は、市場に大きな成長機会をもたらすと予測されています。

例えば、2023年7月、Apollo Hospitals社は、インドの各地にがんのための陽子線治療センターを2カ所新設する計画を発表しました。この拡張計画により、同社は国内のさまざまな地域で市場を拡大し、がんやその他の関連問題に苦しむより幅広い患者層に対応できるようになります。

近年、企業は陽子線や炭素イオンビームの照射を最適化する複雑なアルゴリズムを用いた先進的な治療計画ソフトウェアの導入や、健康な組織へのダメージを最小限に抑えながら治療効果を最大化する個別化治療計画の開発に重点的に取り組んでおり、近い将来、同市場は大きく成長する可能性を秘めています。

これとは別に、改善された治療送達システム、画像誘導技術、適応療法などの技術面での継続的な進歩は、全体的な治療精度と有効性を強化する有利な機会を提供し、ハドロン療法を以前の治療法と比較してさらに魅力的で効果的なものにすることで、長年にわたって大きな市場成長をもたらすでしょう。

ハドロン療法市場レポートハイライト

アルファ粒子線セグメントは、その多くの有益な特性とがん患者の間での認知度の高まりにより、注目すべきシェアを占めました。

小児がんセグメントは、主に世界の小児がん患者の増加により、市場シェアの大半を占めました。

病院セグメントが大きなシェアを占め、業界をリードしています。これは、病院においてこのような治療のための先進的または革新的な機器が容易に利用できることが背景にあります。

北米は、医療インフラへの支出が増加し、認知度が高まっていることから、2022年の世界市場を独占しました。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のハドロン療法市場に関する洞察

  • ハドロン療法市場- 用途のスナップショット
  • ハドロン療法市場力学
    • 促進要因と機会
      • がんの発生率の増加と償還政策の改善が市場の成長を促進
      • 技術と治療法の進歩
    • 抑制要因と課題
      • 限られた臨床証拠と比較研究
  • PESTEL分析
  • ハドロン療法市場応用動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界のハドロン療法市場、タイプ別

  • 主な調査結果
  • イントロダクション
  • 電子線
  • 陽子線
  • ニューロンビーム
  • 炭素イオンビーム
  • アルファ粒子線
  • ベータ粒子線

第6章 世界のハドロン療法市場、エンドユーザー別

  • 主な調査結果
  • イントロダクション
  • 病院
  • 国立大学
  • 研究機関

第7章 世界のハドロン療法市場、用途別

  • 主な調査結果
  • イントロダクション
  • 小児がん
  • 骨・軟部がん
  • 前立腺がん
  • 肺がん
  • 肝臓がん
  • 眼がん
  • 頭頸部がん

第8章 世界のハドロン療法市場、地域別

  • 主な調査結果
  • イントロダクション
    • ハドロン療法市場評価、地域別、2019-2032年
  • ハドロン療法市場-北米
    • 北米：ハドロン療法市場、タイプ別、2019-2032年
    • 北米：ハドロン療法市場、用途別、2019-2032年
    • 北米：ハドロン療法市場、エンドユーザー別、2019～2032年
    • ハドロン療法市場-米国
    • ハドロン療法市場- カナダ
  • ハドロン療法市場- 欧州
    • 欧州：ハドロン療法市場、タイプ別、2019～2032年
    • 欧州：ハドロン療法市場、用途別、2019～2032年
    • 欧州：ハドロン療法市場、エンドユーザー別、2019～2032年
    • ハドロン療法市場- 英国
    • ハドロン療法市場- フランス
    • ハドロン療法市場- ドイツ
    • ハドロン療法市場- イタリア
    • ハドロン療法市場- スペイン
    • ハドロン療法市場- オランダ
    • ハドロン療法市場- ロシア
  • ハドロン療法市場- アジア太平洋
    • アジア太平洋：ハドロン療法市場、タイプ別、2019～2032年
    • アジア太平洋：ハドロン療法市場、用途別、2019～2032年
    • アジア太平洋：ハドロン療法市場、エンドユーザー別、2019～2032年
    • ハドロン療法市場- 中国
    • ハドロン療法市場- インド
    • ハドロン療法市場- マレーシア
    • ハドロン療法市場- 日本
    • ハドロン療法市場- インドネシア
    • ハドロン療法市場- 韓国
  • ハドロン療法市場-中東およびアフリカ
    • 中東およびアフリカ：ハドロン療法市場、タイプ別、2019～2032年
    • 中東およびアフリカ：ハドロン療法市場、用途別、2019～2032年
    • 中東およびアフリカ：ハドロン療法市場、エンドユーザー別、2019～2032年
    • ハドロン療法市場- サウジアラビア
    • ハドロン療法市場- アラブ首長国連邦
    • ハドロン療法市場- イスラエル
    • ハドロン療法市場- 南アフリカ
  • ハドロン療法市場-ラテンアメリカ
    • ラテンアメリカ：ハドロン療法市場、タイプ別、2019-2032年
    • ラテンアメリカ：ハドロン療法市場、用途別、2019-2032
    • ラテンアメリカ：ハドロン療法市場、エンドユーザー別、2019～2032年
    • ハドロン療法市場- メキシコ
    • ハドロン療法市場- ブラジル
    • ハドロン療法市場- アルゼンチン

第9章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Advanced Oncotherapy
  • .Danfysik A/S
  • Elekta
  • Hitachi Ltd
  • IBA Worldwide
  • Koninklijke Philips N.V.
  • Mevion Medical Systems
  • Mitsubishi Electric Corporation
  • Optivus Proton Therapy Inc.
  • ProNova Solutions LLC
  • ProTom International
  • Provision Healthcare
  • Sumitomo Corporation
  • Varian Medical Systems Inc
図表

List of Tables

  • Table 1 Global Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
  • Table 2 Global Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
  • Table 3 Global Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 4 Hadron Therapy Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
  • Table 6 North America: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
  • Table 7 North America: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 8 U.S.: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
  • Table 9 U.S.: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
  • Table 10 U.S.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 11 Canada: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
  • Table 12 Canada: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
  • Table 13 Canada: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 14 Europe: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
  • Table 15 Europe: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
  • Table 16 Europe: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 17 UK: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
  • Table 18 UK: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
  • Table 19 UK: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 20 France: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
  • Table 21 France: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
  • Table 22 France: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 23 Germany: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
  • Table 25 Germany: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 26 Italy: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
  • Table 27 Italy: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
  • Table 28 Italy: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 29 Spain: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
  • Table 30 Spain: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
  • Table 31 Spain: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 35 Russia: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
  • Table 36 Russia: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
  • Table 37 Russia: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 41 China: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
  • Table 42 China: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
  • Table 43 China: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 44 India: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
  • Table 45 India: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
  • Table 46 India: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 50 Japan: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
  • Table 51 Japan: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
  • Table 52 Japan: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 56 South Korea: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
  • Table 57 South Korea: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
  • Table 58 South Korea: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 65 UAE: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
  • Table 66 UAE: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
  • Table 67 UAE: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 68 Israel: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
  • Table 69 Israel: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
  • Table 70 Israel: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 71 South Africa: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
  • Table 72 South Africa: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
  • Table 73 South Africa: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 74 Latin America: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
  • Table 75 Latin America: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
  • Table 76 Latin America: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 77 Mexico: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
  • Table 78 Mexico: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
  • Table 79 Mexico: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 80 Brazil: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
  • Table 81 Brazil: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
  • Table 82 Brazil: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
  • Table 83 Argentina: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
  • Table 84 Argentina: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
  • Table 85 Argentina: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Hadron Therapy Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by End User
  • Figure 7. Global Hadron Therapy Market, by End User, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Type
  • Figure 9. Global Hadron Therapy Market, by Type, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Application
  • Figure 11. Global Hadron Therapy Market, by Application, 2022 & 2032 (USD Billion)
  • Figure 12. Hadron Therapy Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Hadron Therapy Market
目次
Product Code: PM4301

The global hadron therapy market size is expected to reach USD 4.72 billion by 2032, according to a new study by Polaris Market Research. The report "Hadron Therapy Market Share, Size, Trends, Industry Analysis Report, By Type (Electron Beam, Proton Beam, Neutron Beam, Carbon Ion Beam, Alpha Particle Beam, and Beta Particle Beam); By Application; By End User; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The increasing prevalence of cancer globally, growing technological advancements reducing the overall duration of treatment, and a growing number of governments recognizing the potential benefits of hadron therapy and providing financial support for the establishment of new centers are among the prominent factors influencing the growth of the market. Additionally, the increased awareness among healthcare professionals and the public about the importance and availability of improved treatment options and growing educational initiatives and training programs are further anticipated to create significant growth opportunities for the market.

For instance, in July 2023, Apollo Hospitals announced its plan to add two new proton therapy centers for cancer in different parts of India. This expansion plan will allow the company to expand its market across various regions of the country and cater to a wider patient pool suffering from cancer and other related issues.

In recent years, companies have extensively focused on the incorporation of advanced treatment planning software that uses complex algorithms to optimize the delivery of proton and carbon-ion beams along with the development of personalized treatment plans that maximize the therapeutic effect while minimizing damage to healthy tissues, which in turn, generating huge growth potential for the market in the near future.

Apart from this, continuous advancements in terms of technology, such as improved treatment delivery systems, image-guided techniques, and adaptive therapy, provide lucrative opportunities to enhance overall treatment precision and efficacy and make hadron therapy even more attractive and effective as compared to previous therapies, will lead to significant market growth over the years.

Hadron Therapy Market Report Highlights

Alpha particle beam segment accounted for a notable share, on account of its numerous beneficial characteristics and growing awareness among patients with cancer

The pediatric cancer segment held the majority market share, mainly due to rising incidences of pediatric cancer worldwide

The hospitals segment led the industry market with a substantial share, which is driven by the easy availability of advanced or innovative equipment for such therapies in hospitals

North America dominated the global market in 2022, owing to the region's increased expenditure on healthcare infrastructure and greater awareness

The key market players include Mevion Medical Systems, Optivus Proton Therapy, Provision Healthcare, Sumitomo Corporation, and Varian Medical Systems

Polaris Market Research has segmented the hadron therapy market report based on type, application, end user, and region:

Hadron Therapy, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Electron Beam
  • Proton Beam
  • Neutron Beam
  • Carbon Ion Beam
  • Alpha Particle Beam
  • Beta Particle Beam

Hadron Therapy, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Pediatric Cancer
  • Bone & Soft Tissue Cancer
  • Prostate Cancer
  • Lung Cancer
  • Liver Cancer
  • Eye Cancer
  • Head & Neck Cancer

Hadron Therapy, End User Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospitals
  • Government Universities
  • Research Institutions

Hadron Therapy, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Hadron Therapy Market Insights

  • 4.1. Hadron Therapy Market - Application Snapshot
  • 4.2. Hadron Therapy Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing incidences of cancer cases and improvements in reimbursement policies boost the market growth
      • 4.2.1.2. Advancements in technology and treatment modalities
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Limited clinical evidence and comparative studies
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Hadron Therapy Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Hadron Therapy Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
  • 5.3. Electron Beam
    • 5.3.1. Global Hadron Therapy Market, by Electron Beam, by Region, 2019-2032 (USD Billion)
  • 5.4. Proton Beam
    • 5.4.1. Global Hadron Therapy Market, by Proton Beam, by Region, 2019-2032 (USD Billion)
  • 5.5. Neuron Beam
    • 5.5.1. Global Hadron Therapy Market, by Neuron Beam, by Region, 2019-2032 (USD Billion)
  • 5.6. Carbon Ion Beam
    • 5.6.1. Global Hadron Therapy Market, by Carbon Ion Beam, by Region, 2019-2032 (USD Billion)
  • 5.7. Alpha Particle Beam
    • 5.7.1. Global Hadron Therapy Market, by Alpha Particle Beam, by Region, 2019-2032 (USD Billion)
  • 5.8. Beta Particle Beam
    • 5.8.1. Global Hadron Therapy Market, by Beta Particle Beam, by Region, 2019-2032 (USD Billion)

6. Global Hadron Therapy Market, by End User

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
  • 6.3. Hospitals
    • 6.3.1. Global Hadron Therapy Market, by Hospitals, by Region, 2019-2032 (USD Billion)
  • 6.4. Government Universities
    • 6.4.1. Global Hadron Therapy Market, by Government Universities, by Region, 2019-2032 (USD Billion)
  • 6.5. Research Institutions
    • 6.5.1. Global Hadron Therapy Market, by Research Institutions, by Region, 2019-2032 (USD Billion)

7. Global Hadron Therapy Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
  • 7.3. Pediatric Cancer
    • 7.3.1. Global Hadron Therapy Market, by Pediatric Cancer, By Region, 2019-2032 (USD Billion)
  • 7.4. Bone & Soft Tissue Cancer
    • 7.4.1. Global Hadron Therapy Market, by Bone & Soft Tissue Cancer, By Region, 2019-2032 (USD Billion)
  • 7.5. Prostate Cancer
    • 7.5.1. Global Hadron Therapy Market, by Prostate Cancer, By Region, 2019-2032 (USD Billion)
  • 7.6. Lung Cancer
    • 7.6.1. Global Hadron Therapy Market, by Lung Cancer, By Region, 2019-2032 (USD Billion)
  • 7.7. Liver Cancer
    • 7.7.1. Global Hadron Therapy Market, by Liver Cancer, By Region, 2019-2032 (USD Billion)
  • 7.8. Eye Cancer
    • 7.8.1. Global Hadron Therapy Market, by Eye Cancer, By Region, 2019-2032 (USD Billion)
  • 7.9. Head & Neck Cancer
    • 7.9.1. Global Hadron Therapy Market, by Head & Neck Cancer, By Region, 2019-2032 (USD Billion)

8. Global Hadron Therapy Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Hadron Therapy Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Hadron Therapy Market - North America
    • 8.3.1. North America: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
    • 8.3.2. North America: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
    • 8.3.3. North America: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
    • 8.3.4. Hadron Therapy Market - U.S.
      • 8.3.4.1. U.S.: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
    • 8.3.5. Hadron Therapy Market - Canada
      • 8.3.5.1. Canada: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
  • 8.4. Hadron Therapy Market - Europe
    • 8.4.1. Europe: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
    • 8.4.4. Hadron Therapy Market - UK
      • 8.4.4.1. UK: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
    • 8.4.5. Hadron Therapy Market - France
      • 8.4.5.1. France: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
    • 8.4.6. Hadron Therapy Market - Germany
      • 8.4.6.1. Germany: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
    • 8.4.7. Hadron Therapy Market - Italy
      • 8.4.7.1. Italy: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
    • 8.4.8. Hadron Therapy Market - Spain
      • 8.4.8.1. Spain: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
    • 8.4.9. Hadron Therapy Market - Netherlands
      • 8.4.9.1. Netherlands: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
    • 8.4.10. Hadron Therapy Market - Russia
      • 8.4.10.1. Russia: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
  • 8.5. Hadron Therapy Market - Asia Pacific
    • 8.5.1. Asia Pacific: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
    • 8.5.4. Hadron Therapy Market - China
      • 8.5.4.1. China: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
    • 8.5.5. Hadron Therapy Market - India
      • 8.5.5.1. India: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
    • 8.5.6. Hadron Therapy Market - Malaysia
      • 8.5.6.1. Malaysia: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
    • 8.5.7. Hadron Therapy Market - Japan
      • 8.5.7.1. Japan: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
    • 8.5.8. Hadron Therapy Market - Indonesia
      • 8.5.8.1. Indonesia: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
    • 8.5.9. Hadron Therapy Market - South Korea
      • 8.5.9.1. South Korea: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
  • 8.6. Hadron Therapy Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
    • 8.6.4. Hadron Therapy Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
    • 8.6.5. Hadron Therapy Market - UAE
      • 8.6.5.1. UAE: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
    • 8.6.6. Hadron Therapy Market - Israel
      • 8.6.6.1. Israel: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
    • 8.6.7. Hadron Therapy Market - South Africa
      • 8.6.7.1. South Africa: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
  • 8.7. Hadron Therapy Market - Latin America
    • 8.7.1. Latin America: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
    • 8.7.4. Hadron Therapy Market - Mexico
      • 8.7.4.1. Mexico: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
    • 8.7.5. Hadron Therapy Market - Brazil
      • 8.7.5.1. Brazil: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)
    • 8.7.6. Hadron Therapy Market - Argentina
      • 8.7.6.1. Argentina: Hadron Therapy Market, by Type, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Hadron Therapy Market, by Application, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Hadron Therapy Market, by End User, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Advanced Oncotherapy
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. .Danfysik A/S
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Elekta
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Hitachi Ltd
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. IBA Worldwide
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Koninklijke Philips N.V.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Mevion Medical Systems
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Mitsubishi Electric Corporation
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Optivus Proton Therapy Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. ProNova Solutions LLC
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. ProTom International
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Provision Healthcare
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Sumitomo Corporation
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Varian Medical Systems Inc
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development